Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia

NCT04813263 · clinicaltrials.gov ↗
COMPLETED
Status
424
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie